Single low-dose primaquine to reduce malaria transmission.

[1]  N. White.  Primaquine to prevent transmission of falciparum malaria. , 2013, The Lancet. Infectious diseases.

[2]  T. Bousema,et al.  Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial. , 2014, The Lancet. Infectious diseases.

[3]  S. Krudsood,et al.  Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria. , 2006, The American journal of tropical medicine and hygiene.

[4]  F. T. Ter Kuile,et al.  Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria. , 2006, Bulletin of the World Health Organization.

[5]  K. Rieckmann,et al.  Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum. , 1968, Bulletin of the World Health Organization.

[6]  David L. Smith,et al.  Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations , 2009, Malaria Journal.

[7]  Yousef Khader,et al.  Predictors of severe hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency following exposure to oxidant stresses. , 2009, Hematology/oncology and stem cell therapy.

[8]  Geneva,et al.  Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting , 2012, Malaria Journal.